The Prognostic Influence of Chronic Obstructive Pulmonary Disease in Patients Hospitalised for Chronic Heart Failure

AIMS: To investigate the prevalence and the prognostic impact of chronic obstructive pulmonary disease (COPD), in patients hospitalised with chronic heart failure (CHF). METHODS AND RESULTS: In an observational study based on longitudinal information from administrative registers, 1020 patients aged >or=60 years, who were chronically treated for and hospitalised with CHF were identified and followed-up for major events up to 1 year. Median age was 80 years, half of the patients were female and 241 patients (23.6%) had concomitant COPD. There were no differences in the prevalence of cardiovascular and non-cardiovascular comorbidities between CHF patients with or without COPD. However, COPD patients were more often male (60.6% vs. 46.3%), more frequently treated with diuretics (95.9% vs. 91.5%) but less often exposed to beta-blockers (16.2% vs. 22.0%). Significantly higher adjusted in-hospital (HR 1.50 95%CI 1.00-2.26) and out-of-hospital (1.42 1.09-1.86) mortality rates were found in CHF patients with concomitant COPD. A higher occurrence of non-fatal AMI/stroke/rehospitalisation for CHF (1.26 1.01-1.58) as well as hospitalisation for CHF (1.35 1.00-1.82) was associated with COPD. CONCLUSIONS: COPD is a frequent concomitant disease in patients with heart failure and it is an independent short-term prognostic indicator of mortality and cardiovascular comorbidity in patients who have been admitted to hospital for heart failure.